Lisi Zheng

793 total citations · 1 hit paper
16 papers, 597 citations indexed

About

Lisi Zheng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Lisi Zheng has authored 16 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Lisi Zheng's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and RNA Research and Splicing (4 papers). Lisi Zheng is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and RNA Research and Splicing (4 papers). Lisi Zheng collaborates with scholars based in China, United Kingdom and Czechia. Lisi Zheng's co-authors include Zhongming Wu, Shuangwen Li, Xuejun Liu, Jun Zhang, Yuanzhong Wu, Tiebang Kang, Liwen Zhou, Ruhua Zhang, Bin Li and Hui Zhou and has published in prestigious journals such as Science, Oncogene and Free Radical Biology and Medicine.

In The Last Decade

Lisi Zheng

16 papers receiving 593 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy

2020 322 citations Shuangwen Li, Lisi Zheng et al. Free Radical Biology and Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisi Zheng China	11	382	242	230	69	62	16	597
Xiufeng Yu China	20	559 1.5×	353 1.5×	368 1.6×	68 1.0×	74 1.2×	35	873
Baomin Shi China	9	218 0.6×	149 0.6×	90 0.4×	87 1.3×	34 0.5×	14	379
Liping Yang China	11	248 0.6×	137 0.6×	89 0.4×	213 3.1×	102 1.6×	21	578
Yingkun Xu China	15	415 1.1×	277 1.1×	290 1.3×	105 1.5×	58 0.9×	47	672
Weihua Li China	16	450 1.2×	434 1.8×	68 0.3×	93 1.3×	102 1.6×	20	670
Fengping Zheng China	7	259 0.7×	221 0.9×	229 1.0×	55 0.8×	59 1.0×	20	511
Anqi Li China	12	472 1.2×	296 1.2×	43 0.2×	67 1.0×	94 1.5×	23	685

Countries citing papers authored by Lisi Zheng

Since Specialization

Citations

This map shows the geographic impact of Lisi Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisi Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisi Zheng more than expected).

Fields of papers citing papers by Lisi Zheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisi Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisi Zheng. The network helps show where Lisi Zheng may publish in the future.

Co-authorship network of co-authors of Lisi Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Lisi Zheng. A scholar is included among the top collaborators of Lisi Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisi Zheng. Lisi Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zhou, Liwen, Zhilong Chen, Xia Zhang, et al.. (2025). ASB7 is a negative regulator of H3K9me3 homeostasis. Science. 389(6757). 309–316. 1 indexed citations

Zhou, Liwen, Ting Li, Ruhua Zhang, et al.. (2024). Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer. Advanced Science. 11(22). e2310146–e2310146. 11 indexed citations

Zheng, Lisi, Jingxuan Wang, Shan Han, et al.. (2024). The KLF16/MYC feedback loop is a therapeutic target in bladder cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 303–303. 1 indexed citations

Wang, Jingxuan, Lisi Zheng, Xia Zhang, et al.. (2024). Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin. Oncogene. 44(9). 575–586. 1 indexed citations

Wu, Yuanzhong, Liwen Zhou, Yijun Zhang, et al.. (2023). Disrupting the phase separation of KAT8–IRF1 diminishes PD-L1 expression and promotes antitumor immunity. Nature Cancer. 4(3). 382–400. 74 indexed citations

Chen, Jiawei, Lisi Zheng, Zikun Ma, et al.. (2023). NFYC-37 promotes tumor growth by activating the mevalonate pathway in bladder cancer. Cell Reports. 42(8). 112963–112963. 7 indexed citations

Zhong, Li, Jingxuan Wang, Dongming Lv, et al.. (2023). Augmenting L3MBTL2-induced condensates suppresses tumor growth in osteosarcoma. Science Advances. 9(47). eadi0889–eadi0889. 15 indexed citations

Li, Bin, Lisi Zheng, Jie Zhou, et al.. (2022). CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-κB pathways. Science China Life Sciences. 65(8). 1481–1497. 30 indexed citations

Zhou, Liwen, Jiawei Chen, Lisi Zheng, et al.. (2022). Downregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer. Oncogene. 41(28). 3587–3598. 19 indexed citations

10.

Zhou, Zhaohui, Jiawei Chen, Zikun Ma, et al.. (2022). Knockdown of ZBTB11 impedes R‐loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer. Cell Proliferation. 55(12). e13325–e13325. 10 indexed citations

11.

Wu, Yuanzhong, Liwen Zhou, Zifeng Wang, et al.. (2020). Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library. Cancer Biology and Medicine. 17(3). 782–794. 12 indexed citations

12.

Zhou, Liwen, Lisi Zheng, Kaishun Hu, et al.. (2020). SUMOylation stabilizes hSSB1 and enhances the recruitment of NBS1 to DNA damage sites. Signal Transduction and Targeted Therapy. 5(1). 80–80. 26 indexed citations

13.

Wei, Wei, et al.. (2020). Expression and prognostic significance of NKD2 in ovarian cancer. Japanese Journal of Clinical Oncology. 51(3). 459–468. 4 indexed citations

14.

Li, Shuangwen, Lisi Zheng, Jun Zhang, Xuejun Liu, & Zhongming Wu. (2020). Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radical Biology and Medicine. 162. 435–449. 322 indexed citations breakdown →

15.

Yang, Jun, Jun Zhang, Shuangwen Li, et al.. (2020). A bio-inspired injectable hydrogel as a cell platform for real-time glycaemic regulation. Journal of Materials Chemistry B. 8(21). 4627–4641. 10 indexed citations

16.

Yu, Peng, Bin Li, Yanhua Guo, et al.. (2018). miR‐372 and miR‐373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways. Molecular Oncology. 12(11). 1949–1964. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiufeng Yu Breakdown of academic impact, for papers by Baomin Shi Breakdown of academic impact, for papers by Liping Yang Breakdown of academic impact, for papers by Yingkun Xu Breakdown of academic impact, for papers by Weihua Li Breakdown of academic impact, for papers by Fengping Zheng Breakdown of academic impact, for papers by Anqi Li